CLINICAL_TRIALS
trial_result
· 2025-02-10
Clinical Trial Update: Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes [Phase 4]
Summary
A Phase 4 safety study evaluating weekly semaglutide in Chilean adults with Type 2 diabetes has completed, with results posted on 2025-02-10.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2025-02-10